Plain-English translation of NCT07778394 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a digital platform called Vira that's designed to support people taking buprenorphine or methadone for opioid use disorder. The app delivers personalized check-ins and support from peer recovery specialists—people with lived experience of addiction recovery. Researchers want to see if this medication combined with digital support helps people stay in treatment longer and reduces the risk of relapse or overdose.
Many people stop taking medication for opioid use disorder too early, which puts them at serious risk for overdose and death. This trial is testing whether adding accessible digital support and peer connection can help people stay committed to their treatment and improve their chances of lasting recovery.
You likely qualify if…
You likely don't qualify if…
You would use the Vira digital platform on your smartphone, which sends you personalized check-ins and support messages based on your needs and recovery journey. A peer recovery specialist—someone trained through lived experience with addiction recovery—would guide your use of the app and provide encouragement. The study involves 40 participants total, and you would continue taking your prescribed medication while receiving this digital support alongside your usual care.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
United States
Sponsor
Rhode Island Hospital
Collaborators
Ksana Health
Enrollment target
~40 participants
Started
August 2026
Primary completion
December 2026
Age range
22 Years and older
Last updated on clinicaltrials.gov in August 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Susan Ramsey, PhD
Rhode Island Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.